Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Pyruvate Dehydrogenase Complex Deficiency

Metabolic & Lysosomal

Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trials

Also called PDCD, PDH Deficiency, PDHC Deficiency, Pyruvate Dehydrogenase Deficiency, PDHA1 Deficiency, Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E2 deficiency

Cells burn carbohydrates in steps. The pyruvate dehydrogenase complex handles a key one, turning pyruvate into acetyl-CoA, the fuel the mitochondria use to make energy.

In plain words, pyruvate dehydrogenase complex deficiency is a rare genetic condition where cells cannot fully turn sugars and starches into energy. Instead, a substance called lactic acid builds up, and the growing brain takes the most damage.

Get an email when new Pyruvate Dehydrogenase Complex Deficiency trials open or the FDA decides. Get alerts

Pyruvate Dehydrogenase Complex Deficiency

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 2 studies with no phase, like observational studies.

FDA review1

SL1009, Dec 30, 2026

FDA-approved medicines0

No medicine's current FDA label names Pyruvate Dehydrogenase Complex Deficiency yet.

Pyruvate Dehydrogenase Complex Deficiency has no FDA-approved medicines, 4 open or active clinical trials (4 recruiting), and a pending FDA decision on SL1009, due Dec 30, 2026.

Labels checked October 21, 2026.Download the data

More about Pyruvate Dehydrogenase Complex Deficiency

When the complex fails, pyruvate is turned into lactic acid instead. Lactic acid builds up in the blood and brain, and the brain, which needs a constant energy supply, takes the most damage.

Keep reading about Pyruvate Dehydrogenase Complex Deficiency

Most cases come from the PDHA1 gene on the X chromosome, and many of these are new changes that neither parent carries. Changes in PDHX, PDHB, DLD, DLAT or PDP1 cause the rest and are inherited in an autosomal recessive pattern, from both parents.

There is no FDA-approved drug for PDCD as of October 2026. The ketogenic diet, very high in fat and low in carbohydrates, is the standard treatment because it gives the brain fuel that bypasses the broken step. High-dose thiamine (vitamin B1) helps a minority of people, most often those with certain PDHA1 changes, so doctors usually try it. Care involves a metabolic specialist, a dietitian experienced with the ketogenic diet and a neurologist.

What are the symptoms of Pyruvate Dehydrogenase Complex Deficiency?

These are common symptoms of Pyruvate Dehydrogenase Complex Deficiency, and how strong they are varies from person to person.

  • Lactic acid buildup, which can cause vomiting, fast breathing and an abnormal heartbeat
  • Weak, floppy muscles in infancy
  • Developmental delay
  • Seizures
  • Poor coordination or trouble walking
  • A small head size

Who gets Pyruvate Dehydrogenase Complex Deficiency?

Symptoms usually start soon after birth, though onset ranges from before birth to later childhood; in one review the median age at diagnosis was about 20 months. Most cases, 76-85%, come from the PDHA1 gene on the X chromosome. Boys with a PDHA1 change are affected, while girls range from no symptoms to as severe as boys, depending on which X chromosome is active in their cells, so boys and girls are diagnosed about equally often.

Next steps: find trials you might fitsee what is being testedget help payingget alerts

Which new Pyruvate Dehydrogenase Complex Deficiency medicines are in trials?

Investigational medicines Trial Friend tracks for Pyruvate Dehydrogenase Complex Deficiency, with trial results, safety findings and where each one stands.

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Pyruvate Dehydrogenase Complex Deficiency

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Pyruvate Dehydrogenase Complex Deficiency resources

Reputable organizations and medical references for learning more about Pyruvate Dehydrogenase Complex Deficiency, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Pyruvate Dehydrogenase Complex Deficiency

Use this Pyruvate Dehydrogenase Complex Deficiency clinical trial finder to see the 4 studies recruiting patients in the United States and worldwide, with eligibility criteria in plain English. Of these, 2 test a treatment and 2 are observational studies or registries; each card says which. Every trial comes from ClinicalTrials.gov.

FDA decision ahead: SL1009 (sodium dichloroacetate), due December 30, 2026. All upcoming decisions

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

4 active trials worldwide
Filter:
Sort:
RecruitingPatient registry covering many conditionsRecently updatedNCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Sponsor: Sanford Health

The Coordination of Rare Diseases at Sanford (CoRDS) is an international patient registry that serves as a centralized resource for rare disease research. Individuals affected by rare diseases, undiagnosed conditions, and disorders of unknown prevalence may voluntarily contribute...

Ages not specified1 location
Started Jul 2010Updated 2 weeks agoEst. Dec 2100 (~74y 2m)
RecruitingObservational study, no treatment givenRecently updatedNCT03056794

Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies

Intervention: No intervention

Sponsor: University of Pittsburgh

Children and adults with pyruvate dehydrogenase complex deficiency (PDCD) are participating in a research study seeking to better understand the genetic causes, symptoms, usefulness of current treatments, and outcomes for these disorders. The research project involves completing ...

Ages not specified1 location
Started Sep 2015Updated 1 month agoEst. Sep 2030 (~3y 10m)
RecruitingTreatment trialPhase 2No updates in a whileNCT06887777

Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI)

Intervention: Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]

Sponsor: Assistance Publique - Hôpitaux de Paris

This is a phase II, multicenter, prospective, non-comparative clinical trial to assess the efficacy and safety of the treatment of pyruvate dehydrogenase deficiency (PDH) patients with glycerol phenylbutyrate (Ravicti®).

Ages 2 Years to 25 Years1 location
Started Oct 2025Updated 7 months agoEst. Apr 2026
RecruitingTreatment trialPhase 1No updates in a whileNCT06340685

Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency

Intervention: Triheptanoin

Sponsor: Jirair Krikor Bedoyan · Ultragenyx Pharmaceutical Inc

This is a medical research study to test a medication in patients with a disease called Pyruvate Dehydrogenase Complex (PDC) Deficiency. The medication is triheptanoin, which is currently FDA approved for the treatment of Long-Chain Fatty Acid Oxidation Disorders. Previous resear...

Ages 1 Year to 17 Years1 location
Started Jul 2024Updated 8 months agoEst. Dec 2028 (~2y 1m)
Find Pyruvate Dehydrogenase Complex Deficiency trials near you, ranked by distance →
Active trial locations2 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Phase 1
Phase 2
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Pyruvate Dehydrogenase Complex Deficiency trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Pyruvate Dehydrogenase Complex Deficiency foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Pyruvate Dehydrogenase Complex Deficiency patient communities

Facebook groups, Reddit communities and YouTube channels where Pyruvate Dehydrogenase Complex Deficiency patients, caregivers and advocacy groups talk.

Companies developing Pyruvate Dehydrogenase Complex Deficiency treatments

Drugmakers that list Pyruvate Dehydrogenase Complex Deficiency in their rare disease portfolio, 2 in all.

Questions people ask about Pyruvate Dehydrogenase Complex Deficiency